The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief...
Council of Scientific and Industrial Research on September 20 informed that Drugs Controller General of India has approved CSIR's paper-based testing kit called Feluda for COVID-19. CSIR, Director General S Mande said, "Our Delhi CSIR lab's been working on studying CRISPR-Cas immunity. They have experience of working in this particular area before COVID-19 and could repurpose the thing for COVID and developed a paper-based testing kit called Feluda and got formal approval from DCGA. Mande further explained the functioning of the paper based test. "It's different as RTPCR detects RNA and amplifies it using a polymerase chain reaction that is costly. This paper-based test also detects RNA but by a CRISPR guided system. The paper lights up if there is any virus RNA to show a sample is positive, in 45 minutes," he added.
Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites. Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.
Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.
Credit: HT Digital Content Duration: 01:19Published
From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.
Credit: HT Digital Content Duration: 02:18Published
On September 25, a nation-wide protest is observed in wake of farm bills passed in Parliament. Farmers, under aegis of Bharatiya Kisan Union and Revolutionary Marxist Party of India (RMPI), blocked Amritsar-Delhi National Highway near Phillaur in Punjab. Similarly, members of Karnataka State Farmers' Association held protest near Bommanahalli on Karnataka-Tamil Nadu highway. Police personnel deployed in the area to ensure law and order is maintained and COVID safety norms are followed during protest.
With continuous rise in COVID-19 cases, India crossed 58-lakh mark on September 25. A spike of 86,052 new cases and 1,141 deaths reported in last 24 hours. COVID-19 tally stands at 58,18,571 including 9,70,116 active cases, 47,56,165 cured/discharged/migrated and 92,290 deaths. According to Ministry of Health and Family Welfare (MoHFW), more than 13.80 lakh tests have been done in the last 24 hours.
India's COVID-19 tally crossed 56-lakh mark on September 23 with a spike of 83,347 new infections. Total COVID-19 cases in the country stand at 56,46,011. Currently, there are 9,68,377 active cases. With 1,085 deaths in last 24 hours, the death toll rises to 90,020. Indian Council of Medical Research reported that 6,62,79,462 samples were tested up to September 22. Further, the Health Ministry informed that India's COVID-19 testing capacity surges to over 12 lakh daily tests.
Health Secretary Matt Hancock seeks to reassure the public as trials of the Oxford University Covid-19 vaccine have been put on hold owing to a reported side effect in a patient in the UK. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
The Fantasy Premier League has named a new winner for the 2019/20 season afterthe original was disqualified for a breach of the game’s terms and conditions.Josh Bull, a researcher in mathematical oncology at Oxford University, hasreplaced Bulgarian fantasy football manager Aleksandar Antonov two weeks afterthe end of the season.
Credit: PA - Press Association STUDIO Duration: 01:22Published
A large scale trial has kicked off today. Johnson & Johnson's coronavirus vaccine began its Phase 3 clinical trials. This is the fourth COVID-19 vaccine candidate to enter the final stage here in the..
India's patients recovering from COVID-19 cross the 14.2 lakh mark, taking the recovery rate across the country to 68.32 per cent, said the Ministry of Health... Mid-Day Also reported by •WorldNews •Zee News •IndiaTimes